Bactrim Forte Deva — Research Summary
Bactrim Forte Deva is a pharmaceutical antimicrobial compound formulated as a fixed-dose combination for investigational research purposes. This medicinal product combines trimethoprim and sulfamethoxazole in standardised proportions, making it valuable for microbiological research applications. Our Stroid UK Shop maintains strict quality standards for all pharmaceutical research materials. The compound represents a synergistic combination that has been extensively studied in clinical and laboratory settings, providing researchers with a well-characterised antimicrobial reference standard for various in-vitro investigations.
Laboratory Applications
Researchers utilise this antimicrobial combination to study bacterial resistance mechanisms, synergistic antimicrobial effects, and pharmacokinetic interactions in controlled laboratory environments. The fixed-dose formulation enables consistent dosing protocols across experimental studies. Scientists examine its activity against gram-positive and gram-negative bacterial strains in culture-based assays. Additionally, this compound serves as a reference standard in antimicrobial susceptibility testing protocols and biofilm research. Investigators frequently incorporate it into studies evaluating combination therapy approaches and resistance development patterns. Our comprehensive pharmaceutical research compounds support diverse microbiological investigations. The compound’s established clinical profile makes it particularly valuable for comparative efficacy studies alongside our selective modulators and peptide research materials.
Specifications
| Product Code | EU2163 |
|---|---|
| Composition | Verify with supplier |
| Manufacturer | Deva |
| Storage | Room temperature, dry |
| Solubility | Verify with supplier |
| Purity | Pharmaceutical grade |
Research Use Compliance
This product is manufactured exclusively for in-vitro laboratory research and educational purposes. It is not intended for human consumption, clinical application, or therapeutic use. Researchers must follow appropriate safety protocols and institutional guidelines when handling this material. All studies should be conducted in properly equipped laboratory facilities by qualified personnel. This compound is supplied for investigational research only and has not been evaluated for safety or efficacy in human subjects.
